1 Garcia D,Libby E,Crowther MA. The new oral anticoagulants. Blood 2010; 115: 15.
10.1182/blood-2009-09-241851
CAS PubMed Web of Science® Google Scholar
2 Schulman S,Kearon C,Kakkar AK,Mismettk P,Schellong S,Eriksson H,Baanstra D,Schnee J,Goldhaber SZ. N Engl J Med 2009; 361: 2342.
10.1056/NEJMoa0906598
CAS PubMed Web of Science® Google Scholar
3 Schulman S,Wahlander K,Lundstrom T, et al. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 2003; 349: 1713–1721.
10.1056/NEJMoa030104
CAS PubMed Web of Science® Google Scholar
4 Kearon C,Gent M,Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901–907.
10.1056/NEJM199903253401201
CAS PubMed Web of Science® Google Scholar
5 Palumbo A,Rajkumar SV,Dimopoulos MA, et al. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 2008; 22: 414–423.
10.1038/sj.leu.2405062
CAS PubMed Web of Science® Google Scholar
6 Rodger MA,Kahn SR,Wells PS, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 2008; 179: 417–426.
10.1503/cmaj.080493
PubMed Web of Science® Google Scholar
7 Khorana AA,Streiff MB,Farge D, et al. Venous thromboembolism prophylaxis and treatment in cancer: A consensus statement of major guidelines panels and call to action. J Clin Oncol 2009; 27: 4919–4926.
10.1200/JCO.2009.22.3214
CAS PubMed Web of Science® Google Scholar
8 Ling HT,Field JJ,Blinder MA. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: A report of 13 cases and review of the literature. Am J Hematol 2009; 84: 418–421.
10.1002/ajh.21439
CAS PubMed Web of Science® Google Scholar
9 Elliott MA,Heit JA,Pruthi RK, et al. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: A report of four cases and a systematic review of the literature. Eur J Haematol 2009; 83: 365–372.
10.1111/j.1600-0609.2009.01292.x
CAS PubMed Web of Science® Google Scholar
10 Carson KR,Evens AM,Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: A report of 57 cases from the research on adverse drug events and reports project. Blood 2009; 113: 4834–4840.
10.1182/blood-2008-10-186999
CAS PubMed Web of Science® Google Scholar
11 Hasan A,Michel M,Patel V, et al. Repeated courses of rituximab in chronic ITP: Three different regimens. Am J Hematol 2009; 84: 661–665.
10.1002/ajh.21512
CAS PubMed Web of Science® Google Scholar
12 Empson M,Lassere M,Craig J, et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane database of systematic reviews (online). 2005; 2: CD002859.
PubMed Google Scholar

Volume85, Issue3

March 2010

Pages 202-204

ASH 2009 meeting report—Top 10 clinically oriented abstracts in coagulation medicine and platelet disorders^†

References

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

ASH 2009 meeting report—Top 10 clinically oriented abstracts in coagulation medicine and platelet disorders†

References

References

Related

Information

ASH 2009 meeting report—Top 10 clinically oriented abstracts in coagulation medicine and platelet disorders^†